Considering that the expression of MYC is often upregulated in breast cancer, and that it plays a role in promoting proliferation (74, 75), these results suggest that the progestogens evaluated in this study all promote breast cancer cell proliferation, albeit to different extents, via a mechanism requiring an association of the PR and ERα on the MYC promoter. The gene discussed is ESR1; the disease is breast carcinoma.